Ondansetron 51655-0196
Product NDC
51655-0196- Manufacturer
- Northwind Health Company, Llc
- Dosage Form
- Tablet, Orally Disintegrating
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 20, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA090469
Need to source Ondansetron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ondansetron | 8 mg/1 |
Drug Class
Serotonin-3 Receptor Antagonist [EPC]Serotonin 3 Receptor Antagonists [MoA]Serotonin-3 Receptor Antagonist [EPC]
Packaging Options(4)
4 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-04)
10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-53)
8 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-80)
6 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-87)